Zobrazeno 1 - 10
of 26
pro vyhledávání: '"HELENE SJÖGREN"'
Autor:
Se Whee Sammy Park, Susanne Fransson, Fredrik Sundquist, Joachim N. Nilsson, Per Grybäck, Sandra Wessman, Jacob Strömgren, Anna Djos, Henrik Fagman, Helene Sjögren, Kleopatra Georgantzi, Nikolas Herold, Per Kogner, Dan Granberg, Mark N. Gaze, Tommy Martinsson, Kasper Karlsson, Jakob J. E. Stenman
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
In this case report, we present the treatment outcomes of the first patient enrolled in the LuDO-N trial. The patient is a 21-month-old girl diagnosed with high-risk neuroblastoma (NB) and widespread skeletal metastasis. The patient initially underwe
Externí odkaz:
https://doaj.org/article/41ba518bf7834ac3b8d9e8df52b0b021
Autor:
Ulrika Norén-Nyström, Mette K. Andersen, Gisela Barbany, Vaidas Dirse, Martine Eilert-Olsen, Marie Engvall, Arja Harila-Saari, Mats Heyman, Randi Hovland, Satu Häikiö, Jón J. Jónsson, Ritva Karhu, Eigil Kjeldsen, Anna Norberg, Birgitte S. Preiss, Kati Pulkkinen, Petter Quist-Paulsen, Hannele Räsänen, Kjeld Schmiegelow, Anne Seitsonen, Helene Sjögren, Pille Tammur, Bertil Johansson
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e883 (2023)
Externí odkaz:
https://doaj.org/article/951b6b369c904fbc872a2daa70a62c7f
Autor:
Louise Carstam, Alba Corell, Anja Smits, Anna Dénes, Hanna Barchéus, Klara Modin, Helene Sjögren, Sandra Ferreyra Vega, Thomas Olsson Bontell, Helena Carén, Asgeir Store Jakola
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundWhile molecular insights to diffuse lower-grade glioma (dLGG) have improved the basis for prognostication, most established clinical prognostic factors come from the pre-molecular era. For instance, WHO grade as a predictor for survival in
Externí odkaz:
https://doaj.org/article/93b1dcdc11f644caa6798c282abd1682
Autor:
Tajana Tešan Tomić, Josefin Olausson, Annica Wilzén, Magnus Sabel, Katarina Truvé, Helene Sjögren, Sándor Dósa, Magnus Tisell, Birgitta Lannering, Fredrik Enlund, Tommy Martinsson, Pierre Åman, Frida Abel
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175638 (2017)
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. A recurrent feature of PA is deregulation of the mitogen activated protein kinase (MAPK) pathway most often through KIAA1549-BRAF fusion, but also by other BRAF- or RAF1-gene fusion
Externí odkaz:
https://doaj.org/article/602d8a80ec34443192a88cb2a6baca18
Autor:
Tajana Tešan Tomić, Josefin Olausson, Annica Wilzén, Magnus Sabel, Katarina Truvé, Helene Sjögren, Sándor Dósa, Magnus Tisell, Birgitta Lannering, Fredrik Enlund, Tommy Martinsson, Pierre Åman, Frida Abel
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184715 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0175638.].
Externí odkaz:
https://doaj.org/article/822b4d2c56cf4b7aaffee268d1c7880d
Autor:
Dongfeng Chen, Junxiong Zheng, Natalija Gerasimcik, Kristina Lagerstedt, Helene Sjögren, Jonas Abrahamsson, Linda Fogelstrand, Inga-Lill Mårtensson
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162638 (2016)
Precursor-B cell receptor (pre-BCR) signaling represents a crucial checkpoint at the pre-B cell stage. Aberrant pre-BCR signaling is considered as a key factor for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) development. BCP-ALL are belie
Externí odkaz:
https://doaj.org/article/8a3bfa574ead46dfb6a60d2f5dd450b2
Autor:
Lily, Deland, Simon, Keane, Thomas Olsson, Bontell, Henrik, Fagman, Helene, Sjögren, Anders E, Lind, Helena, Carén, Magnus, Tisell, Jonas A, Nilsson, Katarina, Ejeskär, Magnus, Sabel, Frida, Abel
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: Although fusion genes involving the proto-oncogene receptor tyrosine kinase ROS1 are rare in pediatric glioma, targeted therapies with small inhibitors are increasingly being approved for histology-agnostic fusion-positive solid tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fdd0c8f7af2355a7f0a552103fdc21ca
https://pubmed.ncbi.nlm.nih.gov/36316040
https://pubmed.ncbi.nlm.nih.gov/36316040
Autor:
LILY DELAND, SIMON KEANE, THOMAS OLSSON BONTELL, HENRIK FAGMAN, HELENE SJÖGREN, ANDERS E. LIND, HELENA CARÉN, MAGNUS TISELL, JONAS A. NILSSON, KATARINA EJESKÄR, MAGNUS SABEL, FRIDA ABEL
BACKGROUND/AIM: Although fusion genes involving the proto-oncogene receptor tyrosine kinase ROS1 are rare in pediatric glioma, targeted therapies with small inhibitors are increasingly being approved for histology-agnostic fusion-positive solid tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76905c783246a995ac43a1144e0940b
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-22033
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-22033
Publikováno v:
British journal of haematologyReferences. 188(5)
Frequent false-negative FIP1L1-PDGFRA FISH analyses of bone marrow samples from clonal eosinophilia at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff3227244bede6342e48b7941699c98
https://pubmed.ncbi.nlm.nih.gov/28112388
https://pubmed.ncbi.nlm.nih.gov/28112388
Autor:
Katarina Truvé, Frida Abel, Sándor Dósa, Tajana Tešan Tomić, Annica Wilzén, Magnus Tisell, Tommy Martinsson, Josefin Olausson, Fredrik Enlund, Helene Sjögren, Birgitta Lannering, Pierre Åman, Magnus Sabel
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184715 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0175638.].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c11bb06f873e519409ff171f9b06a7b
http://europepmc.org/articles/PMC5589245?pdf=render
http://europepmc.org/articles/PMC5589245?pdf=render